Most Recent
Construction PRO
The ACCC has narrowed the number of local sites in its sights as part of an assessment of Ampol's $1.1 billion acquisition of EG Australia, but the "metropolitan-wide" effects of the merger in four major cities are under the microscope.
Construction PRO
The University of Sydney is seeking to push back the trial date in its six-year-old case against Multiplex over alleged defects at the Charles Perkins Centre, alleging it has recently discovered new problems with the building.
Aged care provider Bupa can't challenge the dismissal of its bid for a quick win in a class action over the standard of care at its facilities, despite a court noting the case has "some curiosities".
Construction PRO
A court has signed off on development plans for the Hughenden Hotel in Sydney’s east featuring a heritage listed Victorian Villa, with the developer overcoming concerns about the lack of parking at the site.
Construction PRO
BP subsidiary Lightsource bp has announced the sale of five of its solar assets to Aula Energy, as part of a plan to shift its focus to hybrid projects.
Construction PRO
Macquarie International Health Clinic must pay an additional $900,000 in security for costs in a decades-long case over a proposed development of a private hospital within the precincts of Sydney's Royal Prince Alfred Hospital.
A class action alleging Sportsbet provided unlawful in-play betting services says the bookmaker’s counterclaim seeking restitution of winnings faces "obvious problems", pointing to difficulties in binding group members.
Construction PRO
Highrise fitout company Starline Interiors has persuaded a court to return a $1.5 million payment dispute to an adjudicator, whose earlier decision against the head contractor on a luxury Gold Coast tower was declared void.
ASIC has filed proceedings against Auto & General, alleging tens of thousands of Budget Direct customers lost discounts they were promised and were overcharged premiums for several years.
Bayer and Teva have lost their challenge to Indian drug maker Cipla’s extension of its patent for an allergy medication, with IP Australia finding a failure to pay renewal fees on time was due to a genuine error.